EUVIMEDEUVIMED entdecken
Kohortenstudie

Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study

Yan-Jiun Huang iD, Jui-An Lin, Wan-Ming Chen iD, Ben-Chang Shia iD, Szu-Yuan Wu iD

Inflammatory Bowel Diseases · 2026

DOI: 10.1093/ibd/izaf304 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Yan-Jiun Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, 110, Taiwan. Hauptthemen laut MEDLINE: Aspirin, Colorectal Neoplasms, Inflammatory Bowel Diseases, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: The Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with inflammatory bowel disease (IBD) are at increased risk of colorectal cancer (CRC). However, the chemopreventive role of aspirin remains uncertain due to conflicting findings in prior studies.

Methods

The study sought to evaluate the association between long-term aspirin use and the risk of CRC and all-cause mortality in patients with IBD. We conducted a nationwide propensity score–matched cohort study using Taiwan’s National Health Insurance Research Database and Cancer Registry from 2008 to 2022. Time-dependent Cox models and Fine and Gray competing risk models were applied.

Results

Among 2743 matched aspirin users and 2743 nonusers, aspirin use was associated with reduced CRC risk (adjusted hazard ratio, 0.42; 95% confidence interval, 0.31-0.57) and lower all-cause mortality (adjusted hazard ratio, 0.66; 95% confidence interval, 0.58-0.74). A dose-response relationship was found for cumulative exposure, while optimal daily intensity was near 80 mg/d.

Conclusions

Long-term use of low-to-moderate-dose aspirin was associated with reduced risks of CRC and mortality in patients with IBD. These findings support aspirin’s potential as a chemopreventive agent and justify further randomized trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinColorectal NeoplasmsInflammatory Bowel DiseasesAnti-Inflammatory Agents, Non-SteroidalHumansFemaleMaleMiddle AgedTaiwanAdultCohort StudiesRisk FactorsAgedFollow-Up StudiesPropensity ScoreProportional Hazards ModelsDose-Response Relationship, Drug

Stichwörter der Autor:innen

aspirinchemopreventioncolorectal cancerinflammatory bowel diseasetime-dependent cox model

Substanzen

AspirinAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, 110, Taiwan.
  • Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
  • Division of General Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, 110, Taiwan.
  • Department of Anesthesiology, School of Medicine, Chung Shan Medical University, Taichung, 40201, Taiwan.
  • Department of Anesthesiology, Chung Shan Medical University Hospital, Taichung, 40201, Taiwan.
  • Center for Regional Anesthesia and Pain Management, Chung Shan Medical University, Taichung, 40201, Taiwan.

ORCID-Profile: Yan-Jiun Huang, Wan-Ming Chen, Ben-Chang Shia, Szu-Yuan Wu

Förderung

  • The Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital

Zitieren

APA

Huang, Y. J., Lin, J. A., Chen, W. M., Shia, B. C., & Wu, S. Y. (2026). Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf304

Vancouver

Huang YJ, Lin JA, Chen WM, Shia BC, Wu SY. Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf304

BibTeX
@article{Huang2026,
  author = {Huang, Yan-Jiun and Lin, Jui-An and Chen, Wan-Ming and Shia, Ben-Chang and Wu, Szu-Yuan},
  title = {Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izaf304}
}
Kostenlos starten →